Covid19 Clinical Trial - Effects of a Home-Based Exercise Intervention in

Status Recruiting

Clinical Trial Summary

The current Coronavirus Disease 2019 (COVID-19) pandemic is the most severe health crisis of the 21st century. This is not only due to the deaths caused by the disease. People that were affected by COVID-19 and supposedly recovered may suffer from long lasting sequelae. The presence of symptoms longer than 3 months after the infection with the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is referred to as Post-COVID-19 Syndrome or Long COVID-19. It is estimated that 10-20 percent of all infected people are affected. The most common symptoms include persistent fatigue, reduced physical capacity, dyspnoea, ageusia, anosmia, musculoskeletal pain and neuropsychological complaints such as depression, anxiety, insomnia and a loss of concentration. Considering the novelty of the pathology, evidence on the successful treatment of Post-COVID/Long-COVID is scarce. Physical activity has been established as a treatment option for chronic diseases that have similar symptomatic manifestations to those of Post-COVID/Long-COVID. For example, exercise therapy has shown positive effects on the health status of patients with lung disease, depression, anxiety, insomnia and cognitive impairment. However, there has been controversy whether so-called Graded Exercise Therapy (GET) is a safe treatment strategy for patients with Chronic Fatigue Syndrome (CFS). This population may experience Post Exertional Malaise (PEM), a worsening of symptoms after physical, cognitive or emotional exertion. Since COVID-19 might be an infectious trigger for CFS, particular caution has to be taken when recruiting participants and when screening them for adverse events and worsening of symptoms during an exercise intervention. It can be hypothesized that patients suffering from Post-COVID/Long-COVID can benefit from exercise in various ways, guaranteed that there is sufficient screening for PEM before and during the intervention and training volume and intensity are increased slowly and progressively. The current study investigates the effects of a home-based concurrent training program on various parameters in people affected by Long COVID.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06073002
Study type	Interventional
Source	University of Vienna
Contact	Johanna Sick, MSc
Phone	+43-1-4277-59118
Email	johanna.sick@univie.ac.at
Status	Recruiting
Phase	N/A
Start date	September 4, 2023
Completion date	April 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05047952` - Vortioxetine for Post-COVID-19 Condition	Phase 2
Completed	`NCT05812209` - Stellate Ganglion Block to Treat Long COVID 19 Case Series
Recruiting	`NCT06091384` - Inspiratory Muscle Strength Training in Post-Covid Syndrome	N/A
Not yet recruiting	`NCT06267300` - Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial	Phase 3
Recruiting	`NCT05986422` - Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)	Phase 2
Not yet recruiting	`NCT05534997` - Rehabilitation Therapy for Post COVID 19 Chronic Fatigue Syndrome	N/A
Recruiting	`NCT05638633` - Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome	Phase 3
Active, not recruiting	`NCT05630040` - VNS for Long-COVID-19	N/A
Recruiting	`NCT05841498` - Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome	N/A
Enrolling by invitation	`NCT05981872` - EFFECT OF COGNITIVE BEHAVIORAL THERAPY ON DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH POST COVID-19	N/A
Active, not recruiting	`NCT05543408` - Long COVID-19 Syndrome in Primary Care: A Novel Protocol of Exercise Intervention "CON-VIDA Clinical Trial"	N/A
Recruiting	`NCT05817032` - Effect of Telerehabilitation Practice in Long COVID-19 Patients	N/A
Recruiting	`NCT05823896` - imPROving Quality of LIFe In the Long COVID Patient	Phase 2
Completed	`NCT05764070` - Impact of Vagus Nerve Stimulation on Post-Aerobic Activity Recovery in Post SARS-CoV-2 Patients	N/A
Completed	`NCT05765591` - Balneotherapy for Patients With Post-acute Coronavirus Disease (COVID) Syndrome	N/A
Recruiting	`NCT05918965` - Vagus Stimulation in Female Long COVID Patients.	N/A
Not yet recruiting	`NCT06231238` - Balance Acceptance and Commitment Therapy for Long COVID	Phase 2
Completed	`NCT06282627` - The COVID HOME Study: Prospective Cohort Study of Non-hospitalised COVID-19 Patients
Completed	`NCT05648734` - Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis
Active, not recruiting	`NCT05753202` - tDCS in Post-COVID Syndrome: Comparison of Two Targets	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of a Home-Based Exercise Intervention in Subjects With Long COVID

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms